1,001
Participants
Start Date
January 20, 2022
Primary Completion Date
March 21, 2023
Study Completion Date
March 24, 2023
Albendazole and Ivermectin fixed dose coformulation
400 mg Albendazole - 9 mg Ivermectin OR 400 mg Albendazole - 18 mg Ivermectin
Albendazole
Albendazole 400mg single dose
Centro de Investigação em Saúde da Manhiça (CISM), Manhiça
Bahir Dar University, Colleges of Medicine and Health Sciences (BDU-CMHS), Bahir Dar
Kenya Medical Research Institute (KEMRI), Nairobi
Collaborators (2)
Leiden University Medical Center
OTHER
Bahir Dar University
OTHER
Centro de Investigacao em Saude de Manhica
OTHER
London School of Hygiene and Tropical Medicine
OTHER
Kenya Medical Research Institute
OTHER
Laboratorios Liconsa
INDUSTRY
Universidad de León
OTHER
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Barcelona Institute for Global Health
OTHER